EP1389052A1 - Sättigungsgefühl vermittelndes diätetisches produkt - Google Patents

Sättigungsgefühl vermittelndes diätetisches produkt

Info

Publication number: EP1389052A1
Authority: EP; European Patent Office
Prior art keywords: yeast; proteins; product; supplements; belonging
Prior art date: 2001-05-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP02732878A

Other languages

English (en)

French (fr)

Inventor

Eric Oriol

Gilles Fromentin

Daniel Tome

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

BIO SPRINGER

Original Assignee

BIO SPRINGER

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-22

Filing date

2002-05-21

Publication date

2004-02-18

2002-05-21 Application filed by BIO SPRINGER filed Critical BIO SPRINGER

2004-02-18 Publication of EP1389052A1 publication Critical patent/EP1389052A1/de

Status Withdrawn legal-status Critical Current

Links

235000005911 diet Nutrition 0.000 title claims abstract description 88
230000000378 dietary effect Effects 0.000 title claims abstract description 35
239000000047 product Substances 0.000 claims abstract description 73
108010058643 Fungal Proteins Proteins 0.000 claims abstract description 53
230000037213 diet Effects 0.000 claims abstract description 53
239000013589 supplement Substances 0.000 claims abstract description 28
238000002360 preparation method Methods 0.000 claims abstract description 15
230000003579 anti-obesity Effects 0.000 claims abstract description 14
235000021245 dietary protein Nutrition 0.000 claims abstract description 12
235000013305 food Nutrition 0.000 claims abstract description 12
240000004808 Saccharomyces cerevisiae Species 0.000 claims description 61
235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 56
235000015872 dietary supplement Nutrition 0.000 claims description 26
239000002830 appetite depressant Substances 0.000 claims description 14
235000001916 dieting Nutrition 0.000 claims description 8
230000037228 dieting effect Effects 0.000 claims description 8
239000000835 fiber Substances 0.000 claims description 7
230000002255 enzymatic effect Effects 0.000 claims description 6
102000015781 Dietary Proteins Human genes 0.000 claims description 5
108010010256 Dietary Proteins Proteins 0.000 claims description 5
241000235070 Saccharomyces Species 0.000 claims description 5
241000124008 Mammalia Species 0.000 claims description 4
235000019789 appetite Nutrition 0.000 claims description 4
230000036528 appetite Effects 0.000 claims description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
239000005905 Hydrolysed protein Substances 0.000 claims description 3
208000008589 Obesity Diseases 0.000 claims description 3
238000004519 manufacturing process Methods 0.000 claims description 3
235000020824 obesity Nutrition 0.000 claims description 3
239000003814 drug Substances 0.000 claims description 2
230000004580 weight loss Effects 0.000 claims description 2
241000700159 Rattus Species 0.000 description 47
235000018102 proteins Nutrition 0.000 description 25
102000004169 proteins and genes Human genes 0.000 description 25
108090000623 proteins and genes Proteins 0.000 description 25
239000008267 milk Substances 0.000 description 22
102000014171 Milk Proteins Human genes 0.000 description 15
108010011756 Milk Proteins Proteins 0.000 description 15
235000021239 milk protein Nutrition 0.000 description 15
241001465754 Metazoa Species 0.000 description 14
230000000694 effects Effects 0.000 description 11
210000000593 adipose tissue white Anatomy 0.000 description 10
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
239000000203 mixture Substances 0.000 description 6
239000012138 yeast extract Substances 0.000 description 6
235000016709 nutrition Nutrition 0.000 description 5
235000013343 vitamin Nutrition 0.000 description 5
239000011782 vitamin Substances 0.000 description 5
229940088594 vitamin Drugs 0.000 description 5
229930003231 vitamin Natural products 0.000 description 5
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
229910052757 nitrogen Inorganic materials 0.000 description 4
230000009467 reduction Effects 0.000 description 4
239000011573 trace mineral Substances 0.000 description 4
235000013619 trace mineral Nutrition 0.000 description 4
210000005253 yeast cell Anatomy 0.000 description 4
206010052804 Drug tolerance Diseases 0.000 description 3
238000007792 addition Methods 0.000 description 3
-1 for example Proteins 0.000 description 3
230000026781 habituation Effects 0.000 description 3
229920001503 Glucan Polymers 0.000 description 2
229920000057 Mannan Polymers 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
239000004365 Protease Substances 0.000 description 2
241000283984 Rodentia Species 0.000 description 2
150000001413 amino acids Chemical class 0.000 description 2
230000006399 behavior Effects 0.000 description 2
235000013325 dietary fiber Nutrition 0.000 description 2
235000020774 essential nutrients Nutrition 0.000 description 2
229910052500 inorganic mineral Inorganic materials 0.000 description 2
239000011707 mineral Substances 0.000 description 2
235000010755 mineral Nutrition 0.000 description 2
235000019624 protein content Nutrition 0.000 description 2
208000035404 Autolysis Diseases 0.000 description 1
206010057248 Cell death Diseases 0.000 description 1
102000002322 Egg Proteins Human genes 0.000 description 1
108010000912 Egg Proteins Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
235000002918 Fraxinus excelsior Nutrition 0.000 description 1
241000282412 Homo Species 0.000 description 1
OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
206010029216 Nervousness Diseases 0.000 description 1
239000005862 Whey Substances 0.000 description 1
102000007544 Whey Proteins Human genes 0.000 description 1
108010046377 Whey Proteins Proteins 0.000 description 1
239000000654 additive Substances 0.000 description 1
210000000577 adipose tissue Anatomy 0.000 description 1
210000003486 adipose tissue brown Anatomy 0.000 description 1
239000002956 ash Substances 0.000 description 1
230000008901 benefit Effects 0.000 description 1
235000010633 broth Nutrition 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
239000002775 capsule Substances 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
230000008859 change Effects 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
235000020940 control diet Nutrition 0.000 description 1
235000014510 cooky Nutrition 0.000 description 1
239000002537 cosmetic Substances 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
230000006735 deficit Effects 0.000 description 1
235000019621 digestibility Nutrition 0.000 description 1
230000029087 digestion Effects 0.000 description 1
230000000816 effect on animals Effects 0.000 description 1
238000005265 energy consumption Methods 0.000 description 1
230000007071 enzymatic hydrolysis Effects 0.000 description 1
238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
235000002864 food coloring agent Nutrition 0.000 description 1
235000012041 food component Nutrition 0.000 description 1
239000005417 food ingredient Substances 0.000 description 1
230000037406 food intake Effects 0.000 description 1
210000003128 head Anatomy 0.000 description 1
230000036541 health Effects 0.000 description 1
210000002216 heart Anatomy 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
239000007788 liquid Substances 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
LUEWUZLMQUOBSB-GFVSVBBRSA-N mannan Chemical class O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
239000012528 membrane Substances 0.000 description 1
238000000034 method Methods 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
229960001412 pentobarbital Drugs 0.000 description 1
WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
239000006187 pill Substances 0.000 description 1
239000000843 powder Substances 0.000 description 1
235000021075 protein intake Nutrition 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
235000015504 ready meals Nutrition 0.000 description 1
230000028043 self proteolysis Effects 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
238000003307 slaughter Methods 0.000 description 1
235000011888 snacks Nutrition 0.000 description 1
241000894007 species Species 0.000 description 1
235000011496 sports drink Nutrition 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
230000001629 suppression Effects 0.000 description 1
239000003826 tablet Substances 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
235000019156 vitamin B Nutrition 0.000 description 1
239000011720 vitamin B Substances 0.000 description 1
229940046001 vitamin b complex Drugs 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
238000005303 weighing Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/347—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of proteins from microorganisms or unicellular algae
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/195—Proteins from microorganisms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents

Definitions

hydrolysed yeast proteins are good quality proteins.
the invention relates first of all to a dietetic product and in particular to a dietetic product belonging to the family of products, supplements or food supplements for dieting or anti-obesity and of products, supplements or food supplements that are appetite suppressant or satiant, containing at least one yeast derivative, said dietetic product containing an effective quantity or dose of food proteins, at least 70% and preferably at least 80%, or preferably at least 90%, are hydrolysed yeast proteins.
the dietetic product can be presented in several forms, inter alia in the form of tablet, pill or capsule, in the form of a cookie or a preparation such as a snack or ready-to-eat product, or in the form of 'a drink or in the form of a powder to dissolve or disperse in a drink.

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Polymers & Plastics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Obesity (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Hematology (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Child & Adolescent Psychology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

EP02732878A 2001-05-22 2002-05-21 Sättigungsgefühl vermittelndes diätetisches produkt Withdrawn EP1389052A1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0106717A FR2825004B1 (fr)	2001-05-22	2001-05-22	Produit dietetique satiant
FR0106717		2001-05-22
PCT/FR2002/001700 WO2002094038A1 (fr)	2001-05-22	2002-05-21	Produit dietetique satiant

Publications (1)

Publication Number	Publication Date
EP1389052A1 true EP1389052A1 (de)	2004-02-18

Family

ID=8863532

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP02732878A Withdrawn EP1389052A1 (de)	2001-05-22	2002-05-21	Sättigungsgefühl vermittelndes diätetisches produkt

Country Status (4)

Country	Link
US (2)	US20040151738A1 (de)
EP (1)	EP1389052A1 (de)
FR (1)	FR2825004B1 (de)
WO (1)	WO2002094038A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA85561C2 (ru) *	2003-08-11	2009-02-10	Лезаффр Э Компани	Применение клеточных стенок дрожжей для лечения или профилактики гипергликемии или для стабилизации содержания сахара в крови
PT1663266E (pt) *	2003-08-11	2013-04-30	Lesaffre & Cie	Paredes celulares de leveduras para o tratamento ou a prevenção de hiperglicemia ou para a estabilização da glicemia
WO2005117933A1 (en) *	2004-05-27	2005-12-15	Campina Nederland Holding B.V.	Use of protein hydrolysates for the manufacture of a medicament for prophylaxis and/or treatment of a dpp-iv mediated condition
ES2381118T3 (es)	2004-12-23	2012-05-23	Campina Nederland Holding B.V.	Hidrolizado de proteínas enriquecido en péptidos de inhibición de DPP-IV y su uso
US8431531B2 (en)	2005-11-30	2013-04-30	Campina Nederland Holding B.V.	Methods for stimulating glucagon-like peptide-1(GLP-1) secretion and treatments comprising same
FR2919187B1 (fr)	2007-07-25	2009-11-27	Lesaffre & Cie	Utilisation d'ecorces de levure pour le traitement et/ou la prevention de l'hyperinsulinemie.
JP4493725B1 (ja) *	2009-10-02	2010-06-30	株式会社ファイナルフューチャーインターナショナル	脂肪分解促進作用を有する組成物
KR100999429B1 (ko) *	2010-04-28	2010-12-09	(주)네오크레마	비만 치료 및 항산화 활성을 갖는 효모 가수분해물
ITMI20111488A1 (it) *	2011-08-03	2013-02-04	Gnosis Spa	Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
WO2021209582A1 (en) *	2020-04-16	2021-10-21	Dsm Ip Assets B.V.	Dark yeast extract

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB698864A (en) *	1945-07-24	1953-10-28	Simon Lyon Ruskin	Improvements relating to the manufacture of nutritional preparations from componentsof the vitamin b-complex
US2631119A (en) *	1950-08-25	1953-03-10	Jr Edgar A Ferguson	Therapeutic appetite satient composition
FR1439073A (fr) *	1964-02-18	1966-05-20	Maggi Ag	Procédé de fabrication d'un hydrolysat de matières protéiques, plus particulièrement de levures
BE675903A (fr) *	1965-02-03	1966-08-01	Agronomique Inst Nat Rech	Procédé de préparation d'aliments azotés.
GB1284357A (en) *	1970-06-05	1972-08-09	Nestle Sa	Flavouring agent
US3852479A (en) *	1970-12-30	1974-12-03	Kikkoman Shoyu Co Ltd	Process for producing a protein hydrolysate
US4118512A (en) *	1974-03-05	1978-10-03	Eichelburg Robert J	Yeast hydrolyzate oral ingesta for animals
GB1457643A (en) *	1974-08-06	1976-12-08	Sarap Cedia	Method of preparing granulated vitaminized coated mineral food complements for animals and products thus obtained
FR2327312A2 (fr) *	1975-10-06	1977-05-06	Hooreman Michel	Produits enzymatiques optimisant la viscosite des mucus et leurs applications
US6143731A (en) *	1989-10-20	2000-11-07	The Collaborative Group, Ltd.	Glucan dietary additives
US5545557A (en) *	1993-04-15	1996-08-13	Cpc International Inc.	Water insoluble coloring agent
US5958755A (en) *	1993-12-01	1999-09-28	Cpc International Inc.	Process of making flavored yeast extracts
US5756135A (en) *	1994-09-15	1998-05-26	Robert D. Seeley Trust	Water insoluble yeast solids product and process of making same
FI952726A7 (fi) *	1995-06-02	1996-12-03	Cultor Oy	Menetelmä ruokatuotteen valmistamiseksi
RU2110934C1 (ru) *	1996-02-09	1998-05-20	Любовь Вячеславовна Римарева	Способ производства сухих пищевых продуктов
US6261606B1 (en) *	1999-09-14	2001-07-17	Natural Compounds, Ltd.	Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions
US6326034B1 (en) *	1999-12-22	2001-12-04	Natural Compounds Ltd	Natural extracted and synthetic antioxidant compositions
US7473426B2 (en) *	2001-02-27	2009-01-06	Yun Seok Choe	Method for selectively inhibiting reuptake of serotonin and norepinephrine using yeast extract

2001
- 2001-05-22 FR FR0106717A patent/FR2825004B1/fr not_active Expired - Fee Related
2002
- 2002-05-21 WO PCT/FR2002/001700 patent/WO2002094038A1/fr not_active Ceased
- 2002-05-21 US US10/478,104 patent/US20040151738A1/en not_active Abandoned
- 2002-05-21 EP EP02732878A patent/EP1389052A1/de not_active Withdrawn
2008
- 2008-08-13 US US12/190,895 patent/US20080299146A1/en not_active Abandoned

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO02094038A1 *

Also Published As

Publication number	Publication date
FR2825004B1 (fr)	2005-02-11
WO2002094038A1 (fr)	2002-11-28
FR2825004A1 (fr)	2002-11-29
US20080299146A1 (en)	2008-12-04
US20040151738A1 (en)	2004-08-05

Legal Events

Date	Code	Title	Description
2004-01-02	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2004-02-18	17P	Request for examination filed	Effective date: 20031215
2004-02-18	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
2004-02-18	AX	Request for extension of the european patent	Extension state: AL LT LV MK RO SI
2006-11-22	17Q	First examination report despatched	Effective date: 20061023
2007-06-13	RIN1	Information on inventor provided before grant (corrected)	Inventor name: BONANNO, LAURENT MICHEL Inventor name: TOME, DANIEL Inventor name: FROMENTIN, GILLES Inventor name: ORIOL, ERIC
2013-05-03	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2013-06-05	18D	Application deemed to be withdrawn	Effective date: 20121201

Publication	Publication Date	Title
US20240382453A1 (en)	2024-11-21	Protein hydrolysates
US20080299146A1 (en)	2008-12-04	Satiating dietetic product
EP0703731B1 (de)	1998-04-08	Polyarminearme nähr- und/oder heilmittelzusammensetzung und therapeutische verwendung derselben
JP2011231097A (ja)	2011-11-17	肥満治療効果及び抗酸化活性を有する酵母加水分解物を含む組成物及びその製造方法
EP1302115A1 (de)	2003-04-16	Verwendung von Cystathionin
CN1437449A (zh)	2003-08-20	含连－乙二硫醇的生理活性剂及其在各种经济分支中的用途
EP0655244B2 (de)	2008-06-11	Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen
EP2092834A1 (de)	2009-08-26	Verfahren und Zusammensetzungen enthaltend Sphingolipid zur Verhinderung oder Behandlung mikrobieller Infektionen
JP2012206942A (ja)	2012-10-25	皮膚萎縮改善剤
US5723443A (en)	1998-03-03	Lipid metabolism promoting agent and its use
JP2022134216A (ja)	2022-09-15	加水分解卵殻膜成分と卵白成分を含む育毛促進用組成物
EP0055172B1 (de)	1985-03-20	Arzneimittel enthaltend Proteinhydrolysate und an polyungesättigten Fettsäuren reiche Lipide
JPWO2006033355A1 (ja)	2008-05-15	皮膚の乾燥予防または改善用経口剤
EP2977047B1 (de)	2022-10-19	Nährmittelzusammensetzung
JPWO2006008890A1 (ja)	2008-05-01	筋肉増強組成物
WO2022043527A1 (fr)	2022-03-03	Utilisation d 'un hydrolysat à hautes teneurs en acides aminés libres dans un aliment pour les crevettes en croissance
EP0703732B1 (de)	1997-09-17	Polyamine nähr-und/oder heilmittelzusammensetzung
JP2003261445A (ja)	2003-09-16	血中中性脂肪低減剤
JP2001046019A (ja)	2001-02-20	柑橘系由来の栄養組成物
EP1523321B1 (de)	2009-12-02	Verwendung von ginkgo biloba extrakten zur förderung der muskelmasse zum nachteil der fettmasse
JP2007230987A (ja)	2007-09-13	抗肥満剤
Lin et al.	2023	Application of Functional Aquafeed in Sustainable Aquaculture
EP3691463B1 (de)	2023-12-13	Appetitanregende zusammensetzung mit hydrolysiertem alpha-s1-casein
WO2007082822A1 (fr)	2007-07-26	Utilisation nouvelle d'une composition alimentaire a usage humain ou veterinaire pauvre en polyamines pour la realisation d'un aliment therapeutique
WO2025028646A1 (ja)	2025-02-06	卵殻膜成分と豆苗エキスを含む育毛促進用組成物